KDA Group Announces Apppointments of New Directors

Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Return to homepage

(TheNewswire)

 

Thetford Mines, Quebec - TheNewswire – June 12, 2020 – KDA Group Inc. (TSXV:KDA) (“KDA” or the “Corporation”) is pleased to announce the appointments of Messrs. Josh Chandler and David Lampron as members of the board of directors of the Corporation (the “Board”).

Mr. Josh Chandler was most recently Vice-President, Global Head of Mergers & Acquisitions as well as Treasurer at Aimia Inc. (“Aimia”), a publicly-traded (TSE: AIM) technology company based in Montreal, Canada with offices and operations across 30 countries. Reporting to the CEO and board of directors, Josh was responsible for the execution of Aimia’s divestiture and capital allocation strategy during a successful multi-year restructuring for the Company. Josh completed 5 divestitures across the UK, APAC, US and Canada regions for cash proceeds of ~$1 billion in conjunction with a rebuild of Aimia’s balance sheet and debt reduction of $2.5 billion to ensure continuity of the go-forward business under a new board of directors in 2020. He also served as the Aimia Board representative at Fractal Analytics, India’s second-largest data analytics company, from 2017 until its sale to Apax Partners in 2019.

Prior to Aimia, Josh was Director of Corporate Development at Gildan (TSE, NYSE: GIL), a leading global apparel manufacturer with over $2.5 billion in revenue and 50,000 employees, where his responsibilities included global M&A (5 completed acquisitions) and key strategic and capital initiatives. He also previously worked as an Investment Banker with Morgan Stanley.

Josh is a CFA charterholder, holds an MBA from the Richard Ivey School of Business at the University of Western Ontario and graduated with great distinction (BComm, Finance) from McGill University. He volunteers as a guest speaker and mentor to both McGill and Ivey MBA programs.

Mr. David Lampron has been working at Persistence Capital Partners (“PCP”) since 2018, where he is involved in managing investments in the portfolio, as well as sourcing and leading the execution of new investment opportunities and divestitures. Persistence Capital Partners is the leading private equity fund in the healthcare space in Canada.

Prior to PCP, David worked for several years at DNA Capital (“DNA”), a Montreal based investment bank boutique. In his capacity as Vice-President while at DNA, David advised numerous private clients and public issuers across various industries on acquisitions, divestitures, private placements and corporate finance mandates. Between DNA and PCP, David has worked on over 50 transactions and mandates representing an aggregate value in excess of $10 billion.

Josh and David are PCP’s nominees for the Board.

Additionally, the Corporation wishes to announce the resignations of Dr. Sheldon Elman and Mr. Stuart M. Elman from the Board. The Corporation wishes to thank Dr. Elman and Mr. Elman for their services and contributions to the Corporation and wishes them well in their future endeavors.

The appointments are subject to the TSX Venture Exchange approval.

 

ABOUT KDA GROUP

KDA Group is a leading innovation and specialized solution provider in the pharmaceutical market. Today, it is a respected name for quality and expertise among the different stakeholders in the pharmaceutical and medical sector. Its management team is guided by a vision of continuing to lead the way in Quebec while extending operations across Canada and internationally. Additional information on the Corporation is available at www.kdagroup.ca and on SEDAR at www.sedar.com.

 

- 30 -

 

CAUTION REGARDING FORWARD-LOOKING STATEMENTS

 

This press release from KDA Group contains forward-looking statements. Forward-looking statements are typically identified by the words assumption, goal, guidance, objective, outlook, strategy, target, and other similar expressions, or future or conditional verbs such as aim, anticipate, believe, predict, could, expect, intend, may, plan, seek, should, strive, and will. By their nature, forward-looking statements require us to make estimates and assumptions and express opinions based on current conditions and anticipated developments, as well as other factors that Management may deem appropriate under the circumstances. There is inherent uncertainty and significant risk in these estimates, assumptions, and opinions, particularly of a commercial, economic, and competitive nature, and they are therefore subject to change. KDA Group cannot guarantee that these estimates, assumptions, and opinions will prove to be accurate.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.

 

INFORMATION

Marc Lemieux

Chief Executive Officer

514 622-7370

[email protected]

 

Copyright (c) 2020 TheNewswire - All rights reserved.